Pre-Open Movers 08/06: (AVCT) (DNLI) (VSTO) Higher; (MVIS) (APRN) (FSLY) Lower (more...)

August 6, 2020 9:23 AM

Pre-Open Stock Movers

Avacta Group plc (NASDAQ: AVCT) 181.6% HIGHER; announced that it has appointed BBI Solutions, part of BBI Group (BBI), to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.

Microvision (NASDAQ: MVIS) 30.8% LOWER; reported Q2 EPS of ($0.02), versus ($0.08) reported last year. Revenue for the quarter came in at $587 thousand, versus $1.24 million reported last year.
Denali Therapeutics Inc. (Nasdaq: DNLI) 28% HIGHER; Biogen Inc. (Nasdaq: BIIB) and Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that they have signed a binding agreement to co-develop and co-commercialize Denalis small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) for Parkinsons disease. Biogen will also receive rights to opt into two programs and a right of first negotiation for two additional programs, in each case for neurodegenerative diseases leveraging Denalis Transport Vehicle (TV) technology platform to cross the blood-brain barrier (BBB).
Ontrak, Inc. (NASDAQ: OTRK) 24% HIGHER; Record Quarterly Revenue of $17.2 Million in Q2 2020, up 124% Year over Year and up 40% from Q1 2020
Anavex Life Sciences Corp. (Nasdaq: AVXL) 23% HIGHER; announced that patients from the ANAVEX®2-73-003 phase 2a Alzheimers disease trial will continue treatment with ANAVEX®2-73 (blarcamesine) via the Australian Government Department of Health - Therapeutic Goods Administration (TGA) compassionate use Special Access Scheme following completion of over 5-years daily dosing of ANAVEX®2-73 (blarcamesine) and recommendation by their physicians.

Digital Turbine (NASDAQ: APPS) 21% HIGHER; reported Q1 EPS of $0.05, $0.04 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $59 million versus the consensus estimate of $48.58 million.

OraSure Technologies, Inc. (NASDAQ: OSUR) 18.8% LOWER; posts Q2 loss

Arlo Technologies, Inc. (NYSE: ARLO) 18.5% HIGHER; reported Q2 EPS of ($0.10), $0.31 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $66.6 million versus the consensus estimate of $54.83 million. Arlo Technologies, Inc. sees Q3 2020 EPS of ($0.33)-($0.24), versus the consensus of ($0.30). Arlo Technologies, Inc. sees Q3 2020 revenue of $85-95 million, versus the consensus of $81.74 million.

Blue Apron Holdings, Inc. (NYSE: APRN) 17.9% LOWER; announced the pricing of its underwritten public offering of 4,000,000 shares of its Class A common stock at a public offering price of $9.25 per share

Vista Outdoor (NYSE: VSTO) 15.4% HIGHER; reported Q1 EPS of $0.51, $0.51 better than the analyst estimate of $0.00. Revenue for the quarter came in at $479 million versus the consensus estimate of $405.81 million. Vista Outdoor sees Q2 2021 EPS of $0.60-$0.70, versus the consensus of $0.46. Vista Outdoor sees Q2 2021 revenue of $495-515 million, versus the consensus of $468.4 million.

Wix.com (NASDAQ: WIX) 15% LOWER; reported Q2 EPS of ($0.26), $0.50 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $236.1 million versus the consensus estimate of $233.25 million.

CommScope (NASDAQ: COMM) 15% HIGHER; reported Q2 EPS of $0.32, $0.13 better than the analyst estimate of $0.19. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.06 billion.

Fastly, Inc. (NYSE: FSLY) 13.3% LOWER; reported Q2 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $75 million versus the consensus estimate of $71.4 million. Fastly, Inc. sees Q3 2020 EPS of ($0.01), versus the consensus of ($0.03). Fastly, Inc. sees Q3 2020 revenue of $73.5-85.5 million, versus the consensus of $71.95 million. Fastly, Inc. sees FY2020 EPS of ($0.06)-($0.01), versus the consensus of ($0.13). Fastly, Inc. sees FY2020 revenue of $290-300 million, versus the consensus of $287.24 million.

Tivity Health, Inc. (NASDAQ: TVTY) 12% HIGHER; reported Q2 EPS of $0.79, $0.72 better than the analyst estimate of $0.07. Revenue for the quarter came in at $262.6 million versus the consensus estimate of $225.73 million.

Western Digital (NASDAQ: WDC) 12% LOWER; reported Q4 EPS of $1.23, $0.02 better than the analyst estimate of $1.21. Revenue for the quarter came in at $4.29 billion versus the consensus estimate of $4.34 billion. Western Digital sees Q1 2021 EPS of $0.45-$0.65, versus the consensus of $1.33. Western Digital sees Q1 2021 revenue of $3.7-3.9 billion, versus the consensus of $4.35 billion.

MannKind Corporation (NASDAQ: MNKD) 11.8% LOWER; 2Q 2020 Afrezza Net Revenue of $7.0 million; +15% vs. 2Q 2019.

Medifast (NYSE: MED) 10.8% LOWER; reported Q2 EPS of $1.96, $0.13 better than the analyst estimate of $1.83. Revenue for the quarter came in at $220 million versus the consensus estimate of $191.76 million.

Sonos (NASDAQ: SONO) 10.5% LOWER; reported Q3 EPS of ($0.52), which may not compare to the analyst estimate of ($0.27). Revenue for the quarter came in at $249.3 million versus the consensus estimate of $235.78 million. Sonos sees FY2020 revenue of $1.277-1.292 billion, versus the consensus of $1.25 billion.

3D Systems (NYSE: DDD) 8% LOWER; reported Q2 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $112.1 million versus the consensus estimate of $117.93 million.

Globus Medical (NYSE: GMED) 7.7% HIGHER; reported Q2 EPS of $0.07, $0.18 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $148.9 million versus the consensus estimate of $99.73 million.

Inseego Corp. (NASDAQ: INSG) 7.4% LOWER; reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $79.77 million.

ADT Corp. (NYSE: ADT) 7% LOWER; reported Q2 EPS of ($0.14), $0.43 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.25 billion. ADT Corp. sees FY2020 revenue of $5.05-5.3 billion, versus the consensus of $5.17 billion. Adjusted EBITDA $2,100 - $2,200 million

Camping World (NYSE: CWH) 6.4% LOWER; reported Q2 EPS of $1.62, $0.99 better than the analyst estimate of $0.63. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.4 billion.

HubSpot (NYSE: HUBS) 6.4% HIGHER; reported Q2 EPS of $0.38, $0.14 better than the analyst estimate of $0.24. Revenue for the quarter came in at $203.6 million versus the consensus estimate of $195.62 million. HubSpot sees Q3 2020 EPS of $0.11-$0.13, versus the consensus of $0.13. HubSpot sees Q3 2020 revenue of $210-211 million, versus the consensus of $200.45 million. HubSpot sees FY2020 EPS of $0.92-$0.96, versus the consensus of $0.94. HubSpot sees FY2020 revenue of $828-832 million, versus the consensus of $806.9 million.

Collegium Pharma (NASDAQ: COLL) 6% HIGHER; reported Q2 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $78.06 million versus the consensus estimate of $74.4 million.

Turtle Beach (NASDAQ: HEAR) 6% HIGHER; reported Q2 EPS of $0.51, $0.14 better than the analyst estimate of $0.37. Revenue for the quarter came in at $79.7 million versus the consensus estimate of $75.36 million.

Zynga (NASDAQ: ZNGA) 5.3% HIGHER; reported Q2 EPS of ($0.16), may not compare to the analyst estimate of $0.08. Revenue for the quarter came in at $452 million, may not compare versus the consensus estimate of $502.8 million. Zynga sees Q3 2020 revenue of $445 million, may not compare versus the consensus of $450.1 million.

Bristol-Myers Squibb (NYSE: BMY) 5.3% HIGHER; BMY and Pfizer (NYSE: PFE) won a trial court ruling that upheld patents on Eliquis, according to Bloomberg

Carvana Co. (NYSE: CVNA) 4% LOWER; reported Q2 EPS of ($0.62), $0.21 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.14 billion. Retail units sold totaled 55,098, an increase of 25%.

Jack in the Box (NASDAQ: JACK) 4% HIGHER; reported Q3 EPS of $1.37, $0.34 better than the analyst estimate of $1.03. Revenue for the quarter came in at $242.28 million versus the consensus estimate of $240.36 million.

Categories

Special Reports